NCT01532336 - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

August 31, 2014

Conditions

Adenoviral Conjunctivitis

Interventions

DRUG

NVC-422 Solution, 0.3%

NVC-422 Ophthalmic Solution dropped onto the eye

DRUG

NVC-422 Vehicle Solution

NVC-422 Vehicle Ophthalmic Solution dropped onto the eye

Trial Locations (58)

10250

Nugegoda

10350

Kalubowila

11010

Colombo

11500

Negombo

11570

Rockville Centre

11801

Hicksville

15206

Pittsburgh

27101

Winston-Salem

27262

High Point

28803

Asheville

29306

Spartanburg

29414

Charleston

31701

Albany

32250

Jacksonville Beach

33603

Tampa

33901

Fort Myers

41701

Hazard

60026

Glenview

61615

Peoria

63131

St Louis

64154

Kansas City

66204

Shawnee Mission

90048

Los Angeles

91205

Glendale

92115

San Diego

94954

Petaluma

96734

Kailua

01890

Winchester

50070-040

Recife

21941-913

Rio de Janeiro

90035-903

Porto Alegre

89201-010

Joinville

01221-020

São Paulo

04023-062

São Paulo

04502-001

São Paulo

18031-060

Sorocaba

500 034

Hyderabad

500 096

Hyderabad

380 016

Ahmedabad

395 001

Surat

560 010

Bangalore

560 054

Bangalore

695 011

Thiruvanathapuram

400 004

Mumbai

400 020

Mumbai

400 080

Mumbai

400 602

Mumbai

110 002

Daryāganj

110 608

New Dehli

334 001

Bikaner

302 004

Jaipur

302 015

Jaipur

600 010

Chennai

636 004

Salem

530 013

Visakhapatnam

700 073

Kolkata

01000

Colombo

Unknown

Colombo